Bp PLC Astrazeneca PLC Transaction History

Bp PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $23.5 Million - $25.7 Million	-422,414 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$48.42 - $60.18 $6.84 Million - $8.5 Million	-141,271 Reduced 25.06%	422,414 $25.3 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $6.77 Million - $7.82 Million	-143,579 Reduced 20.3%	563,685 $28 Million
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $4.69 Million - $5.6 Million	96,604 Added 15.82%	707,264 $35.3 Million
Q3 2020 Oct 30, 2020	BUY	$53.07 - $61.1 $32.4 Million - $37.3 Million	610,660 New	610,660 $33.5 Million

1,334

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.